Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 25, 2026Cancer Research

Abstract A039: Novel microRNA-mediated G2/M vulnerabilities in glioblastoma revealed by a CRISPR/Cas9 screen

View Full Paper
Ask AI
Bookmark
Share

Authors

IGIulia A GrigoreARA. RajagopalJCJonathan Tak-Sum Chow

Discussion

Loading...

Member takes

Overview

Novel microRNA candidates reveal G2/M vulnerabilities in glioblastoma, suggesting new therapeutic targets.

Key Points

  • To identify essential microRNAs that regulate glioblastoma stem cell survival and their therapeutic potential.
  • Conducted a microRNA essentiality screen using a CRISPR/Cas9 library in glioblastoma stem cell cultures.
  • Identified and validated 23 crucial microRNAs for U3013MG glioblastoma stem cells' survival.
  • Employed neurosphere assays to evaluate tumor-initiating potential following microRNA knockout.
  • Assessed the effect of microRNA inhibition in combination with standard chemotherapy.
  • Knockout of identified microRNAs induced consistent G2/M cell cycle arrest across tested cell lines.
  • This G2/M arrest led to increased cell death and mitotic abnormalities in glioblastoma cells.
  • Five specific microRNAs were highlighted as crucial for glioblastoma growth and tumor progression.

Cite This Study

Grigore et al. (2026) studied this question.

synapsesocial.com/papers/69c37b81b34aaaeb1a67df8dhttps://doi.org/10.1158/1538-7445.brain26-a039
View Full Paper
Ask AI
Bookmark
Share